Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00380198 · ClinicalTrials.gov registry record · Phase 3
A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.
A Phase 3 study, sponsored by Forest Laboratories.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1,500
- Enrollment target
NCT00380198: Clinical Trial Phase 3 study, sponsored by Forest Laboratories.
NCT00380198 is a Phase 3 study that was terminated before completion, run by Forest Laboratories. The registered enrollment target is 1,500 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00380198, a Phase 3 study, was terminated before completion, sponsored by Forest Laboratories.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1,500 participants
- Enrollment target
Study Summary
The purpose of this clinical research study is to compare Apadenoson and adenosine to treadmill exercise stress SPECT MPI
Interventions
- DRUG Apadenoson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2006-07 |
| Est. Completion | 2006-11 |
| Phase | Phase 3 |
Why NCT00380198 stopped before completion
NCT00380198 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% higher).
The record links to 0 conditions, and to 1 intervention - of which Apadenoson is the first listed.
NCT00380198 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00380198 about?
NCT00380198 is a clinical study titled "A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.". The purpose of this clinical research study is to compare Apadenoson and adenosine to treadmill exercise stress SPECT MPI
What is the current status of trial NCT00380198?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1,500 participants. The study started on 2006-07. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00380198?
The interventions under investigation include: Apadenoson (DRUG).
Who is sponsoring clinical trial NCT00380198?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00380198's enrollment target sits among peer trials
1,500 158th of 2000 higher than 1,838 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia